{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:37:17Z","timestamp":1767706637724},"reference-count":40,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1620\/tjem.241.201","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T03:04:26Z","timestamp":1489806266000},"page":"201-208","source":"Crossref","is-referenced-by-count":7,"title":["Galectin-9 as a Predictive Marker for the Onset of Immune-Related Adverse Effects Associated with Anti-CCR4 MoAb Therapy in Patients with Adult T Cell Leukemia"],"prefix":"10.1620","volume":"241","author":[{"given":"Tareg Omer","family":"Mohammed","sequence":"first","affiliation":[{"name":"Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haorile","family":"Chagan-Yasutan","sequence":"additional","affiliation":[{"name":"Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University"},{"name":"Disaster-related Infectious Disease, International Research Institute of Disaster Science, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Ashino","sequence":"additional","affiliation":[{"name":"Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University"},{"name":"Disaster-related Infectious Disease, International Research Institute of Disaster Science, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakana","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kumamoto Shinto General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kumamoto Shinto General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kumamoto Shinto General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kumamoto Shinto General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Niki","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Kagawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Suzushima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kumamoto Shinto General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Hattori","sequence":"additional","affiliation":[{"name":"Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University"},{"name":"Graduate School of Health Science and Social Welfare, KIBI International University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Anderson, A.C., Joller, N. &amp; Kuchroo, V.K. (2016) Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. <i>Immunity<\/i>, 44, 989-1004.","DOI":"10.1016\/j.immuni.2016.05.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Chagan-Yasutan, H., Saitoh, H., Ashino, Y., Arikawa, T., Hirashima, M., Li, S., Usuzawa, M., Oguma, S., Telan, E.F.O., Obi, C.L. &amp; Hattori, T. (2009) Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. <i>Tohoku J. Exp. Med.<\/i>, 218, 285-292.","DOI":"10.1620\/tjem.218.285"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chagan-Yasutan, H., Shiratori, B., Siddiqi, U.R., Saitoh, H., Ashino, Y., Arikawa, T., Hirashima, M. &amp; Hattori, T. (2010) The increase of plasma galectin-9 in a patient with insulin allergy: a case report. <i>Clin. Mol. Allergy<\/i>, 8, 12.","DOI":"10.1186\/1476-7961-8-12"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chagan-Yasutan, H., Ndhlovu, L.C., Lacuesta, T.L., Kubo, T., Leano, P.S., Niki, T., Oguma, S., Morita, K., Chew, G.M., Barbour, J.D., Telan, E.F., Hirashima, M., Hattori, T. &amp; Dimaano, E.M. (2013) Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. <i>J. Clin. Virol.<\/i>, 58, 635-640.","DOI":"10.1016\/j.jcv.2013.10.022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chagan-Yasutan, H., Tsukasaki, K., Takahashi, Y., Oguma, S., Harigae, H., Ishii, N., Zhang, J., Fukumoto, M. &amp; Hattori, T. (2011) Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia. <i>Leuk. Res.<\/i>, 35, 1484-1490.","DOI":"10.1016\/j.leukres.2011.05.011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Dardalhon, V., Anderson, A.C., Karman, J., Apetoh, L., Chandwaskar, R., Lee, D.H., Cornejo, M., Nishi, N., Yamauchi, A., Quintana, F.J., Sobel, R.A., Hirashima, M. &amp; Kuchroo, V.K. (2010) Tim-3\/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. <i>J. Immunol.<\/i>, 185, 1383-1392.","DOI":"10.4049\/jimmunol.0903275"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Dembele, B.P., Chagan-Yasutan, H., Niki, T., Ashino, Y., Tangpukdee, N., Shinichi, E., Krudsood, S., Kano, S. &amp; Hattori, T. (2016) Plasma levels of Galectin-9 reflect disease severity in malaria infection. <i>Malar. J.<\/i>, 15, 403.","DOI":"10.1186\/s12936-016-1471-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Fuji, S. &amp; Shindo, T. (2016) Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma. <i>Stem Cell Investig.<\/i>, 3, 70.","DOI":"10.21037\/sci.2016.09.13"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Fujihara, S., Mori, H., Kobara, H., Rafiq, K., Niki, T., Hirashima, M. &amp; Masaki, T. (2013) Galectin-9 in cancer therapy. <i>Recent Pat. Endocr. Metab. Immune Drug Discov.<\/i>, 7, 130-137.","DOI":"10.2174\/1872214811307020006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Gupta, M., Jafri, K., Sharim, R., Silverman, S., Sindher, S.B., Shahane, A. &amp; Kwan, M. (2015) Immune reconstitution inflammatory syndrome associated with biologic therapy. <i>Curr. Allergy Asthma Rep.<\/i>, 15, 499.","DOI":"10.1007\/s11882-014-0499-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hattori, T., Asou, N., Suzushima, H., Takatsuki, K., Tanaka, K., Naito, K., Natori, H. &amp; Oizumi, K. (1991) Leukaemia of novel gastrointestinal T-lymphocyte population infected with HTLV-I. <i>Lancet<\/i>, 337, 76-77.","DOI":"10.1016\/0140-6736(91)90737-A"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hattori, T., Uchiyama, T., Toibana, T., Takatsuki, K. &amp; Uchino, H. (1981) Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. <i>Blood<\/i>, 58, 645-647.","DOI":"10.1182\/blood.V58.3.645.645"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ikeda, K., Oka, M., Yamada, Y., Soda, H., Fukuda, M., Kinoshita, A., Tsukamoto, K., Noguchi, Y., Isomoto, H., Takeshima, F., Murase, K., Kamihira, S., Tomonaga, M. &amp; Kohno, S. (1999) Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes. <i>Int. J. Cancer<\/i>, 82, 599-604.","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<599::AID-IJC21>3.0.CO;2-R"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Inagaki, A., Ishida, T., Ishii, T., Komatsu, H., Iida, S., Ding, J., Yonekura, K., Takeuchi, S., Takatsuka, Y., Utsunomiya, A. &amp; Ueda, R. (2006) Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia\/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. <i>Int. J. Cancer<\/i>, 118, 3054-3061.","DOI":"10.1002\/ijc.21688"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ishida, T., Ito, A., Sato, F., Kusumoto, S., Iida, S., Inagaki, H., Morita, A., Akinaga, S. &amp; Ueda, R. (2013) Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia \/ lymphoma. <i>Cancer Sci.<\/i>, 104, 647-650.","DOI":"10.1111\/cas.12116"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ishida, T., Joh, T., Uike, N., Yamamoto, K., Utsunomiya, A., Yoshida, S., Saburi, Y., Miyamoto, T., Takemoto, S., Suzushima, H., Tsukasaki, K., Nosaka, K., Fujiwara, H., Ishitsuka, K., Inagaki, H., et al. (2012) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. <i>J. Clin. Oncol.<\/i>, 30, 837-842.","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ishida, T. &amp; Ueda, R. (2011) Immunopathogenesis of lymphoma: focus on CCR4. <i>Cancer Sci.<\/i>, 102, 44-50.","DOI":"10.1111\/j.1349-7006.2010.01767.x"},{"key":"18","unstructured":"Ishida, T., Utsunomiya, A., Iida, S., Inagaki, H., Takatsuka, Y., Kusumoto, S., Takeuchi, G., Shimizu, S., Ito, M., Komatsu, H., Wakita, A., Eimoto, T., Matsushima, K. &amp; Ueda, R. (2003) Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome. <i>Clin. Cancer Res.<\/i>, 9, 3625-3634."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Karube, K., Ohshima, K., Tsuchiya, T., Yamaguchi, T., Kawano, R., Suzumiya, J., Utsunomiya, A., Harada, M. &amp; Kikuchi, M. (2004) Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells. <i>Br. J. Haematol.<\/i>, 126, 81-84.","DOI":"10.1111\/j.1365-2141.2004.04999.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kataoka, K., Nagata, Y., Kitanaka, A., Shiraishi, Y., Shimamura, T., Yasunaga, J., Totoki, Y., Chiba, K., Sato-Otsubo, A., Nagae, G., Ishii, R., Muto, S., Kotani, S., Wattani, Y., Takeda, J., et al. (2015) Integrated molecular analysis of adult T cell leukemia\/lymphoma. <i>Nat. Genet.<\/i>, 47, 1304-1315.","DOI":"10.1038\/ng.3415"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kawano, N., Kuriyama, T., Sonoda, K.H., Yoshida, S., Yamashita, K., Ochiai, H., Shimoda, K., Ishikawa, F., Ueda, A. &amp; Kikuchi, I. (2016) Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014). <i>Intern. Med.<\/i>, 55, 1439-1445.","DOI":"10.2169\/internalmedicine.55.6312"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Kohno, T., Yamada, Y., Akamatsu, N., Kamihira, S., Imaizumi, Y., Tomonaga, M. &amp; Matsuyama, T. (2005) Possible origin of adult T-cell leukemia\/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. <i>Cancer Sci.<\/i>, 96, 527-533.","DOI":"10.1111\/j.1349-7006.2005.00080.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Monney, L., Sabatos, C.A., Gaglia, J.L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E.A., Coyle, A.J., Sobel, R.A., Freeman, G.J. &amp; Kuchroo, V.K. (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. <i>Nature<\/i>, 415, 536-541.","DOI":"10.1038\/415536a"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Mori, N. &amp; Prager, D. (1998) Interleukin-10 gene expression and adult T-cell leukemia. <i>Leuk. Lymphoma<\/i>, 29, 239-248.","DOI":"10.3109\/10428199809068561"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Oomizu, S., Arikawa, T., Niki, T., Kadowaki, T., Ueno, M., Nishi, N., Yamauchi, A., Hattori, T., Masaki, T. &amp; Hirashima, M. (2012) Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion. <i>PLoS One<\/i>, 7, e48574.","DOI":"10.1371\/journal.pone.0048574"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Roncador, G., Garcia, J.F., Garcia, J.F., Maestre, L., Lucas, E., Menarguez, J., Ohshima, K., Nakamura, S., Banham, A.H. &amp; Piris, M.A. (2005) FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma. <i>Leukemia<\/i>, 19, 2247-2253.","DOI":"10.1038\/sj.leu.2403965"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Saitoh, H., Ashino, Y., Chagan-Yasutan, H., Niki, T., Hirashima, M. &amp; Hattori, T. (2012) Rapid decrease of plasma galectin-9 levels in patients with acute HIV infection after therapy. <i>Tohoku J. Exp. Med.<\/i>, 228, 157-161.","DOI":"10.1620\/tjem.228.157"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Seki, M., Oomizu, S., Sakata, K.M., Sakata, A., Arikawa, T., Watanabe, K., Ito, K., Takeshita, K., Niki, T., Saita, N., Nishi, N., Yamauchi, A., Katoh, S., Matsukawa, A., Kuchroo, V. &amp; Hirashima, M. (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. <i>Clin. Immunol.<\/i>, 127, 78-88.","DOI":"10.1016\/j.clim.2008.01.006"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Shimoyama, M. (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). <i>Br. J. Haematol.<\/i>, 79, 428-437.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"30","unstructured":"Suzushima, H., Hattori, T., Asou, N., Wang, J.X., Nishikawa, K., Okubo, T., Anderson, P. &amp; Takatsuki, K. (1991) Discordant gene and surface expression of the T-cell receptor\/CD3 complex in adult T-cell leukemia cells. <i>Cancer Res.<\/i>, 51, 6084-6088."},{"key":"31","doi-asserted-by":"crossref","unstructured":"Tamaki, K., Kinjo, T., Aoyama, H., Tomoyose, T., Nakachi, S., Hanashiro, T., Shimabukuro, N., Tedokon, I., Morichika, K., Nishi, Y., Taira, N., Fujita, J., Yoshimi, N., Fukushima, T. &amp; Masuzaki, H. (2015) Fatal pneumonia and viremia due to human parainfluenza virus type 1 in a patient with adult T-cell leukemia-lymphoma treated with mogamulizumab. <i>J. Infect. Chemother.<\/i>, 21, 820-823.","DOI":"10.1016\/j.jiac.2015.07.001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Tsukasaki, K., Utsunomiya, A., Fukuda, H., Shibata, T., Fukushima, T., Takatsuka, Y., Ikeda, S., Masuda, M., Nagoshi, H., Ueda, R., Tamura, K., Sano, M., Momita, S., Yamaguchi, K., Kawano, F., et al. (2007) VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. <i>J. Clin. Oncol.<\/i>, 25, 5458-5464.","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. &amp; Uchino, H. (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. <i>Blood<\/i>, 50, 481-492.","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"34","unstructured":"Walker, N.F., Scriven, J., Meintjes, G. &amp; Wilkinson, R.J. (2015) Immune reconstitution inflammatory syndrome in HIV-infected patients. <i>HIV AIDS <\/i>(<i>Auckl<\/i>.), 7, 49-64."},{"key":"35","doi-asserted-by":"crossref","unstructured":"Wang, F., Wan, L., Zhang, C., Zheng, X., Li, J. &amp; Chen, Z.K. (2009) Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. <i>Immunobiology<\/i>, 214, 342-349.","DOI":"10.1016\/j.imbio.2008.10.007"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Yamada, Y., Ohmoto, Y., Hata, T., Yamamura, M., Murata, K., Tsukasaki, K., Kohno, T., Chen, Y., Kamihira, S. &amp; Tomonaga, M. (1996) Features of the Cytokines Secreted by Adult T Cell Leukemia (ATL) Cells. <i>Leuk. Lymphoma<\/i>, 21, 443-447.","DOI":"10.3109\/10428199609093442"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Yamamura, Y., Hattori, T., Obaru, K., Sakai, K., Asou, N., Takatsuki, K., Ohmoto, Y., Nomiyama, H. &amp; Shimada, K. (1989) Synthesis of a novel cytokine and its gene (LD78) expressions in hematopoietic fresh tumor cells and cell lines. <i>J. Clin. Invest.<\/i>, 84, 1707-1712.","DOI":"10.1172\/JCI114353"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yasuda, N., Lai, P.K., Ip, S.H., Kung, P.C., Hinuma, Y., Matsuoka, M., Hattori, T., Takatsuki, K. &amp; Purtilo, D.T. (1988) Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. <i>Blood<\/i>, 71, 1021-1026.","DOI":"10.1182\/blood.V71.4.1021.1021"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Yoshie, O., Fujisawa, R., Nakayama, T., Harasawa, H., Tago, H., Izawa, D., Hieshima, K., Tatsumi, Y., Matsushima, K., Hasegawa, H., Kanamaru, A., Kamihira, S. &amp; Yamada, Y. (2002) Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. <i>Blood<\/i>, 99, 1505-1511.","DOI":"10.1182\/blood.V99.5.1505"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Zhu, C., Anderson, A.C., Schubart, A., Xiong, H., Imitola, J., Khoury, S.J., Zheng, X.X., Strom, T.B. &amp; Kuchroo, V.K. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. <i>Nat. Immunol.<\/i>, 6, 1245-1252.","DOI":"10.1038\/ni1271"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/3\/241_201\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T02:17:24Z","timestamp":1601777844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/3\/241_201\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.241.201","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}